DaVita Inc. (DVA) — Fair Value Analysis

Base-case fair value (P50): $221.33 · Current price: $234.91 · Verdict: Fairly Valued

The Verdict on DVA

Based on our FairCurve Monte Carlo simulations, DaVita (DVA) is currently Fairly Valued. The analysis indicates a median fair value (P50) of $221.33, standing in close proximity to DVA's current trading price of $234.91. This suggests that, at present levels, the market's valuation largely aligns with our intrinsic value assessment derived from thousands of forward-looking scenarios. The calculated -5.8% against the current price reinforces this fair valuation, indicating neither a significant discount nor a premium. Investors seeking substantial near-term dislocation might find DVA's current position less compelling, reflecting a balanced risk-reward profile according to our models.

How DVA stacks up against Healthcare

DaVita's operational and financial health is categorized as "average" relative to its Healthcare sector peers. This average quality tier plays a crucial role in the Monte Carlo simulation outcomes, influencing the range and probability distributions for its future cash flows. While DVA doesn't present a compelling case for being deeply undervalued at its $234.91, its average quality also prevents a strong overvaluation verdict. The sector context, combined with the $221.33 fair value, suggests that DVA is operating within expected parameters for a company of its profile, with its current valuation of $234.91 reflecting this stability.

What this means for investors

For investors, DVA's Fairly Valued assessment means that significant capital appreciation from a re-rating appears less likely based on current fundamentals and market price of $234.91. The modest -5.8% confirms that the stock is not presenting a deeply discounted entry point. While there isn't an immediate strong buy signal, the analysis does not suggest a significant overvaluation either, aligning its $221.33 with the market. For those interested in the full spectrum of potential outcomes, including the specific bear and bull case scenarios, a free FairCurve account provides access to the complete Monte Carlo distribution and its associated probabilities. Sign up for FairCurve to see the full bear/bull distribution and track DVA's fair value as new fundamentals are released.